The Use of Samsung Health and ECG M-Trace Base II Applications in the Secondary Prevention After Stroke
NCT ID: NCT04821518
Last Updated: 2021-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
52 participants
OBSERVATIONAL
2020-11-15
2021-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Stroke Riskometer Apps In Improving Awareness and Stroke Risk Probability
NCT04529681
Effects of Patient-centered Stroke Educating System: a Randomized Controlled Trial
NCT02591511
Affect of Multiple Health Education on Medication Persistence and Clinical Prognosis of Ischemic Stroke Patients
NCT02140619
Computer Scan Based Analysing System on Improving Stroke Management Quality Evaluation
NCT03684629
Efficacy and Safety of Reperfusion Therapy for Minor Ischemic Stroke in China
NCT07322835
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The study group (post-stroke)
The study group consisted of 26 patients in whom ischaemic brain stroke occurred within 14 days before the admission to the Clinical Department, and were hospitalised at the Department of Neurological Rehabilitation of the Clinical Department of Rehabilitation in the Wiktor Dega Orthopaedic and Rehabilitation Clinical Hospital in Poznań
No interventions assigned to this group
The control group
The control group was composed of 26 healthy individuals recruited from the hospital staff who did not experience stroke.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. stroke confirmed in the diagnostic imaging records
3. score \>3 on Lovett's scale of muscle strength in the paretic limbs
4. score above 15 in Barthel's scale of performance in activities of daily living
5. score below 12 in the National Institutes of Health Stroke Scale (NIHSS)
6. available complete medical records concerning the assessed risk factors of recurrent CVD event
7. lack of concomitant pulmonary diseases including chronic obstructive pulmonary disease and bronchial asthma
Exclusion Criteria
2. lack of diagnostic imaging scans confirming the occurrence of stroke
3. hospital stay at the Department of Neurological Rehabilitation for more than 14 days from the occurrence of stroke
4. incomplete medical records concerning the assessed risk factors of recurrent CVD event
5. score \>3 on Lovett's scale of muscle strength in the paretic limbs
6. score below 14 in Barthel's scale of performance in activities of daily living
7. score above 13 in the NIHSS scale
8. occurrence of factors limiting walking ability, such as diagnosed pulmonary diseases, unstable angina, severe valvular heart diseases, cardiomyopathy, musculoskeletal or autoimmune diseases.
42 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Poznan University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ewa Chlebuś
Role: PRINCIPAL_INVESTIGATOR
Clinic Rehabilitation, University of Medical Sciences in Poznań
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Rehabilitation and Physiotherapy Rehabilitation,
Poznan, , Poland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lucki M, Chlebus E, Warenczak A, Lisinski P. The Use of Samsung Health and ECG M-Trace Base II Applications for the Assessment of Exercise Tolerance in the Secondary Prevention in Patients after Ischemic Stroke. Int J Environ Res Public Health. 2021 May 27;18(11):5753. doi: 10.3390/ijerph18115753.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1/2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.